8v9o: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "8v9o" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
==Imaging scaffold engineered to bind the therapeutic protein target BARD1== | |||
<StructureSection load='8v9o' size='340' side='right'caption='[[8v9o]], [[Resolution|resolution]] 3.81Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[8v9o]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8V9O OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8V9O FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.81Å</td></tr> | |||
[[Category: | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr> | ||
[[Category: Agdanowski | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8v9o FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8v9o OCA], [https://pdbe.org/8v9o PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8v9o RCSB], [https://www.ebi.ac.uk/pdbsum/8v9o PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8v9o ProSAT]</span></td></tr> | ||
[[Category: | </table> | ||
[[Category: | __TOC__ | ||
[[Category: | </StructureSection> | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: Synthetic construct]] | |||
[[Category: Agdanowski MP]] | |||
[[Category: Arbing MA]] | |||
[[Category: Castells-Graells R]] | |||
[[Category: Sawaya MR]] | |||
[[Category: Yeates TO]] | |||
Revision as of 05:26, 15 May 2024
Imaging scaffold engineered to bind the therapeutic protein target BARD1
| ||||||||||||
